475 related articles for article (PubMed ID: 34440788)
1. Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders.
Valori CF; Possenti A; Brambilla L; Rossi D
Cells; 2021 Aug; 10(8):. PubMed ID: 34440788
[TBL] [Abstract][Full Text] [Related]
2. Protective Functions of Reactive Astrocytes Following Central Nervous System Insult.
Linnerbauer M; Rothhammer V
Front Immunol; 2020; 11():573256. PubMed ID: 33117368
[TBL] [Abstract][Full Text] [Related]
3. Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain.
Donnelly CR; Andriessen AS; Chen G; Wang K; Jiang C; Maixner W; Ji RR
Neurotherapeutics; 2020 Jul; 17(3):846-860. PubMed ID: 32820378
[TBL] [Abstract][Full Text] [Related]
4. Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases.
Finsterwald C; Magistretti PJ; Lengacher S
Curr Pharm Des; 2015; 21(25):3570-81. PubMed ID: 26166612
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychopharmacological understanding for therapeutic application of morphinans.
Shin EJ; Hong JS; Kim HC
Arch Pharm Res; 2010 Oct; 33(10):1575-87. PubMed ID: 21052935
[TBL] [Abstract][Full Text] [Related]
6. Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches.
Garzón D; Cabezas R; Vega N; Ávila-Rodriguez M; Gonzalez J; Gómez RM; Echeverria V; Aliev G; Barreto GE
J Mol Neurosci; 2016 Apr; 58(4):483-92. PubMed ID: 26803310
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte modulation of neurotoxic injury.
Aschner M; Sonnewald U; Tan KH
Brain Pathol; 2002 Oct; 12(4):475-81. PubMed ID: 12408234
[TBL] [Abstract][Full Text] [Related]
8. mGlu3 receptor and astrocytes: partners in neuroprotection.
Durand D; Carniglia L; Caruso C; Lasaga M
Neuropharmacology; 2013 Mar; 66():1-11. PubMed ID: 22564439
[TBL] [Abstract][Full Text] [Related]
9. Development of Precision Small-Molecule Proneurotrophic Therapies for Neurodegenerative Diseases.
Janssens J; Lu D; Ni B; Chadwick W; Siddiqui S; Azmi A; Etienne H; Jushaj A; van Gastel J; Martin B; Maudsley S
Vitam Horm; 2017; 104():263-311. PubMed ID: 28215298
[TBL] [Abstract][Full Text] [Related]
10. Astrocytes: Emerging Therapeutic Targets in Neurological Disorders.
Valori CF; Guidotti G; Brambilla L; Rossi D
Trends Mol Med; 2019 Sep; 25(9):750-759. PubMed ID: 31122805
[TBL] [Abstract][Full Text] [Related]
11. The Spatiotemporal Coupling: Regional Energy Failure and Aberrant Proteins in Neurodegenerative Diseases.
Virtuoso A; Colangelo AM; Maggio N; Fennig U; Weinberg N; Papa M; De Luca C
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768733
[TBL] [Abstract][Full Text] [Related]
12. The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration.
Hinkle JT; Dawson VL; Dawson TM
Mov Disord; 2019 Jul; 34(7):959-969. PubMed ID: 31136698
[TBL] [Abstract][Full Text] [Related]
13. Astrocytes as targets for neuroprotective drugs.
Darlington CL
Curr Opin Investig Drugs; 2005 Jul; 6(7):700-3. PubMed ID: 16044665
[TBL] [Abstract][Full Text] [Related]
14. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
[TBL] [Abstract][Full Text] [Related]
15. Protective mechanisms of adenosine in neurons and glial cells.
Schubert P; Ogata T; Marchini C; Ferroni S; Rudolphi K
Ann N Y Acad Sci; 1997 Oct; 825():1-10. PubMed ID: 9369970
[TBL] [Abstract][Full Text] [Related]
16. Targeting reactive astrogliosis by novel biotechnological strategies.
Colangelo AM; Cirillo G; Lavitrano ML; Alberghina L; Papa M
Biotechnol Adv; 2012; 30(1):261-71. PubMed ID: 21763415
[TBL] [Abstract][Full Text] [Related]
17. Implications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases.
Afridi R; Rahman MH; Suk K
Neurobiol Dis; 2022 Nov; 174():105874. PubMed ID: 36154877
[TBL] [Abstract][Full Text] [Related]
18. Resolution-Associated Molecular Patterns (RAMPs) as Endogenous Regulators of Glia Functions in Neuroinflammatory Disease.
Wenzel TJ; Kwong E; Bajwa E; Klegeris A
CNS Neurol Disord Drug Targets; 2020; 19(7):483-494. PubMed ID: 32614758
[TBL] [Abstract][Full Text] [Related]
19. Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders.
Liu B; Teschemacher AG; Kasparov S
Glia; 2017 Aug; 65(8):1205-1226. PubMed ID: 28300322
[TBL] [Abstract][Full Text] [Related]
20. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
Kuo YM; Hsu PC; Hung CC; Hu YY; Huang YJ; Gan YL; Lin CH; Shie FS; Chang WK; Kao LS; Tsou MY; Lee YH
Mol Neurobiol; 2019 Dec; 56(12):8451-8474. PubMed ID: 31257558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
